IGF2 has a dual role in promoting tumor growth while contributing to metastatic dissemination and immune evasion: it seems that this pathway enhances the epithelial–mesenchymal transition (EMT), a critical process of cancer metastasization, by activating downstream signaling pathways such as MAPK and PI3K/Akt. The gene discussed is AKT1; the disease is neoplasm.